Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...
This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...
TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by the end of the year Tessera to receive $150 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback